Skip to main content
Skip to main content
Normal View Dyslexic View

Author response: Identification of patient characteristics that may improve procedure selection for the treatment of carotid stenosis

BJSA
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
Correspondence to: Andreas Kuehnl (e-mail: a.kuehnl@tum.de)
Department for Vascular and Endovascular Surgery
Klinikum rechts der Isar
Technical University of Munich
Ismaninger Str. 22
Munich 81675
Germany
_________
BJS, https://doi.org/10.1093/bjs/znae227, published 03 October 2024
_________
Dear Editor
Thank you very much to Mr Kuang and colleagues for your comment and the positive remarks about our study. We fully agree with your comments and recommendations. We would have liked to include further variables in the analysis, but unfortunately these were not available. The collection of underlying quality assurance data in Germany is carried out on a statutory basis. The primary purpose of use is quality assurance of virtually all carotid endarterectomy and carotid artery stenting procedures. The analysis is therefore, as mentioned, a secondary data analysis which unfortunately does not include all scientifically interesting variables. We were only able to work with variables that were prescribed by the legislator for the primary purpose of national quality assurance.
We fully agree with Kuang et al. that variables such as antiplatelet medication, anticoagulation, statin use, low density lipoprotein levels, smoking, hypertension, renal insufficiency, diabetes mellitus as well as morphological characteristics such as vascular anatomy, calcification, plaque composition, etc. would be very useful variables that could have been investigated in more detail. Unfortunately, however, these are not recorded in Germany as part of quality assurance. Nevertheless, in conjunction with the present study (and previous studies) we have repeatedly been in correspondence with the responsible institutions to increase the number of recorded variables and to expand the database for scientific purposes in the future.
We also agree with the comment that the data only relates to the German population and therefore cannot be generalized globally. We therefore believe that, in addition to the technical, medical and morphological criteria, population-specific factors should of course also be analysed in future studies to make the best individual treatment decision for our patients.
Sincerely,
Andreas Kuehnl
for the ISAR-IQ Team
Copied!